Literature DB >> 2328252

The cesium-induced delay in myoblast membrane fusion is accompanied by changes in isolated membrane lipids.

M T Santini1, P L Indovina, A Cantafora, I Blotta.   

Abstract

We have recently demonstrated that cesium ions delay the sharp decrease in both membrane conductivity and membrane permittivity of chick embryo myoblasts seen at fusion (Santini, M.T., Bonincontro, A., Cametti, C. and Indovina, P.L. (1988) Biochim. Biophys. Acta 945, 56-64). Analysis of the conductivity dispersion data (obtained in the radiowave frequency range) indicated that cesium delays fusion by about 30 h. We suggested that cesium is affecting both active ionic transport by blocking potassium channels as well as interfering with membrane lipid and/or protein charges. In the present study, we have investigated both the possible role of membrane lipids in myoblast fusion and the possible effects of cesium on these lipids. Our data indicate that lipid changes do occur in the isolated myoblast plasma membrane of controls during myogenic differentiation especially prior to fusion and that in cesium cultures these variations do not occur. These variations are in accordance with current membrane fusion theory. Specifically, there is a decrease in bilayer-stabilizing lipids (phosphatidylcholine) and an increase in bilayer-destabilizing ones (phosphatidylethanolamine and phosphatidic acid) and cholesterol during the fusion process. In addition, although slight, during fusion there appears to be a decrease in phosphatidylinositol which is believed to be involved in the inositol phosphate second messenger system. In cesium cultures, in which fusion is greatly delayed, the same lipid changes do not take place and those that are observed seem to reflect the fusion delay.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328252     DOI: 10.1016/0005-2736(90)90426-o

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Role of an inward rectifier K+ current and of hyperpolarization in human myoblast fusion.

Authors:  J H Liu; P Bijlenga; J Fischer-Lougheed; T Occhiodoro; A Kaelin; C R Bader; L Bernheim
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

2.  Effects of cesium on in vitro myoblast differentiation: an electron microscopic study.

Authors:  W Malorni; P L Indovina; G Arancia; S Meschini; M T Santini
Journal:  In Vitro Cell Dev Biol       Date:  1990-04

3.  Polyphosphoinositide inclusion in artificial lipid bilayer vesicles promotes divalent cation-dependent membrane fusion.

Authors:  S A Summers; B A Guebert; M F Shanahan
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

4.  Developmental and metabolic effects of disruption of the mouse CTP:phosphoethanolamine cytidylyltransferase gene (Pcyt2).

Authors:  Morgan D Fullerton; Fatima Hakimuddin; Marica Bakovic
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

5.  Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis.

Authors:  K Emoto; T Kobayashi; A Yamaji; H Aizawa; I Yahara; K Inoue; M Umeda
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Cesium ions influence cultured cell behavior by modifying specific subcellular components: the role of membranes and of the cytoskeleton.

Authors:  M T Santini; S Paradisi; E Straface; W Malorni
Journal:  Cell Biol Toxicol       Date:  1993 Jul-Sep       Impact factor: 6.691

7.  Modeling degranulation with liposomes: effect of lipid composition on membrane fusion.

Authors:  T G Brock; K Nagaprakash; D I Margolis; J E Smolen
Journal:  J Membr Biol       Date:  1994-08       Impact factor: 1.843

8.  Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration.

Authors:  Shuzhi Teng; David Stegner; Qin Chen; Tsunaki Hongu; Hiroshi Hasegawa; Li Chen; Yasunori Kanaho; Bernhard Nieswandt; Michael A Frohman; Ping Huang
Journal:  Mol Biol Cell       Date:  2014-11-26       Impact factor: 4.138

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.